HDAC2 and neoplasm: With these in vitro anti-tumor effects of HDAC2 inhibition, we demonstrated a remarkable suppression of tumor mass growth in vivo and a lower tumor incidence by using these cell lines in an experimental mouse xenograft model for cancer (Figs. 6E and 6F).